Cardioprotection thread, page-432

Here is an interesting article Doxorubicin Market Size, Share - Global Report 2035 (researchnester.com) - you are likely already aware of it - about doxorubicin worldwide sales estimate forecast, which considering a bisantrene plus doxorubicin combination are mind boggling. This is why I am very excited and can't wait to get RC220 into the clinic and get proof that it works both as a cardio protective as well as an improved cancer treatment in combination with doxorubicin. Race / Pfizer might see an opportunity to have another patent for this combination. Just my understanding, please correct if you - or anyone else - disagrees of my thoughts.